Yale Smoking Cessation and Alcohol Treatment Research Clinic at CMHC
Mission
To develop and evaluate treatments for smoking and for problematic alcohol consumption.
Presently, we are conducting three studies:
- Project Choice: This study tests a novel treatment approach to reducing heavy drinking in young adults. Click here to go to the Project Choice website.
- Smoking cessation for smokers who drink regularly: This study evaluates the combination of brief smoking cessation counseling and the FDA-approved medication varenicline (Chantix). Click here to learn more about this study
- Smoking cessation for head and neck cancer patients: This study compares varenicline (Chantix) to the nicotine patch for smoking cessation in patients treated for head and neck cancer. Click here to learn more about this study.
Who is elligible?
- Project Choice: Adults ages 18-25 who drink at least twice per week and meet other inclusion criteria.
- Smoking Cessation for Drinkers: Adults ages 18-75 who smoke regularly and drink at least weekly.
- Smoking Cessation for Head and Neck Cancer Patients: Adult Yale Cancer Center patients who smoke at least 10 cigarettes per day.
Location
SATU
1 Long Wharf Drive, Suite 18
New Haven, CT 06511
Yale Faculty
Fucito, Lisa
Assistant Professor of Psychiatry
Leeman, Robert , Jr
Assistant Professor of Psychiatry
Meandzija, Borislav
Assistant Clinical Professor of Psychiatry (Social Work)
Chief, Behavioral Health, Yale Health
Psychoanalyst
Psychiatrist
O'Malley, Stephanie
Professor of Psychiatry
Director, Division of Substance Abuse Research in Psychiatry
Toll, Benjamin
Assistant Professor of Psychiatry
Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven
Contact Us
For more information about Project Choice, please call Vanessa at 203-974-5763 or email project.choice@yale.edu
For more information about our smoking cessation studies, please call Susan at 203-974-7588 or email susan.neveu@yale.edu
